Russell Investments Group’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.69K | Buy |
+196
| New | +$2.69K | ﹤0.01% | 3548 |
|
|
2024
Q4 | – | Sell |
-253
| Closed | -$3.21K | – | 3801 |
|
|
2024
Q3 | $3.21K | Hold |
253
| – | – | ﹤0.01% | 3301 |
|
|
2024
Q2 | $4.25K | Hold |
253
| – | – | ﹤0.01% | 3250 |
|
|
2024
Q1 | $3.8K | Hold |
253
| – | – | ﹤0.01% | 2979 |
|
|
2023
Q4 | $3.8K | Hold |
253
| – | – | ﹤0.01% | 2935 |
|
|
2023
Q3 | $3.55K | Hold |
253
| – | – | ﹤0.01% | 3192 |
|
|
2023
Q2 | $2.62K | Hold |
253
| – | – | ﹤0.01% | 3202 |
|
|
2023
Q1 | $2.34K | Buy |
+253
| New | +$2.34K | ﹤0.01% | 2999 |
|
|
2022
Q3 | – | Sell |
-1,962
| Closed | -$16K | – | 2980 |
|
|
2022
Q2 | $16K | Hold |
1,962
| – | – | ﹤0.01% | 2815 |
|
|
2022
Q1 | $17K | Hold |
1,962
| – | – | ﹤0.01% | 2687 |
|
|
2021
Q4 | $18K | Sell |
1,962
-55,035
| -97% | -$505K | ﹤0.01% | 2955 |
|
|
2021
Q3 | $958K | Buy |
56,997
+121
| +0.2% | +$2.03K | ﹤0.01% | 2207 |
|
|
2021
Q2 | $867K | Buy |
56,876
+22,923
| +68% | +$349K | ﹤0.01% | 2379 |
|
|
2021
Q1 | $660K | Sell |
33,953
-23,268
| -41% | -$452K | ﹤0.01% | 2404 |
|
|
2020
Q4 | $1.03M | Buy |
+57,221
| New | +$1.03M | ﹤0.01% | 2103 |
|
|
2018
Q4 | – | Sell |
-2,523
| Closed | -$119K | – | 3038 |
|
|
2018
Q3 | $119K | Buy |
+2,523
| New | +$119K | ﹤0.01% | 2736 |
|